ETXPF
Price
$0.13
Change
-$0.01 (-7.14%)
Updated
Apr 16 closing price
Capitalization
75.96M
ZIVO
Price
$14.91
Change
+$0.69 (+4.85%)
Updated
Jun 24 closing price
Capitalization
56.86M
Interact to see
Advertisement

ETXPF vs ZIVO

Header iconETXPF vs ZIVO Comparison
Open Charts ETXPF vs ZIVOBanner chart's image
E-Therapeutics
Price$0.13
Change-$0.01 (-7.14%)
Volume$10K
Capitalization75.96M
Zivo Bioscience
Price$14.91
Change+$0.69 (+4.85%)
Volume$516
Capitalization56.86M
ETXPF vs ZIVO Comparison Chart in %
Loading...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETXPF vs. ZIVO commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETXPF is a Buy and ZIVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ETXPF: $0.13 vs. ZIVO: $14.91)
Brand notoriety: ETXPF and ZIVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETXPF: 100% vs. ZIVO: 35%
Market capitalization -- ETXPF: $75.96M vs. ZIVO: $56.86M
ETXPF [@Biotechnology] is valued at $75.96M. ZIVO’s [@Biotechnology] market capitalization is $56.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETXPF’s FA Score shows that 0 FA rating(s) are green whileZIVO’s FA Score has 0 green FA rating(s).

  • ETXPF’s FA Score: 0 green, 5 red.
  • ZIVO’s FA Score: 0 green, 5 red.
According to our system of comparison, both ETXPF and ZIVO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ZIVO’s TA Score shows that 4 TA indicator(s) are bullish.

  • ZIVO’s TA Score: 4 bullish, 3 bearish.

Price Growth

ETXPF (@Biotechnology) experienced а 0.00% price change this week, while ZIVO (@Biotechnology) price change was +4.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.67%. For the same industry, the average monthly price growth was +32.94%, and the average quarterly price growth was +6.79%.

Industries' Descriptions

@Biotechnology (+3.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETXPF($76M) has a higher market cap than ZIVO($56.9M). ETXPF YTD gains are higher at: 0.000 vs. ZIVO (-30.651).
ETXPFZIVOETXPF / ZIVO
Capitalization76M56.9M134%
EBITDAN/A-16.29M-
Gain YTD0.000-30.651-
P/E RatioN/AN/A-
RevenueN/A122K-
Total CashN/A517K-
Total DebtN/A975K-
FUNDAMENTALS RATINGS
ZIVO: Fundamental Ratings
ZIVO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ETXPFZIVO
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
16%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
15%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X108385.5700001057.875000
+0.99%
Bitcoin cryptocurrency
SPY614.913.04
+0.50%
SPDR® S&P 500® ETF
GME23.590.04
+0.17%
GameStop Corp
AAPL201.00N/A
N/A
Apple
TSLA323.63-2.15
-0.66%
Tesla

ETXPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETXPF has been loosely correlated with MTVA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ETXPF jumps, then MTVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETXPF
1D Price
Change %
ETXPF100%
N/A
MTVA - ETXPF
52%
Loosely correlated
-7.35%
TYRA - ETXPF
42%
Loosely correlated
N/A
KPRX - ETXPF
37%
Loosely correlated
-3.63%
COGT - ETXPF
33%
Poorly correlated
-3.14%
BRTX - ETXPF
24%
Poorly correlated
-3.59%
More

ZIVO and

Correlation & Price change

A.I.dvisor tells us that ZIVO and MDXXF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZIVO and MDXXF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZIVO
1D Price
Change %
ZIVO100%
N/A
MDXXF - ZIVO
22%
Poorly correlated
+7.07%
ATXS - ZIVO
21%
Poorly correlated
N/A
ETXPF - ZIVO
21%
Poorly correlated
N/A
COGT - ZIVO
20%
Poorly correlated
-3.14%
CLSD - ZIVO
20%
Poorly correlated
-5.06%
More